Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Retrospective, Postmarketing Study of Safety and Performance of Hydroxytite, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation.

NCT02218788 is registered in ClinicalTrials.gov with Panaxia Ltd as lead sponsor.

NCT NCT02218788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02218788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Retrospective, Postmarketing Study of Safety and Performance of Hydroxytite, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation.
Lead sponsor
Panaxia Ltd
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
August 31, 2018
Enrollment
218 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

wrinkles